DE69520376D1 - Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe - Google Patents
Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffeInfo
- Publication number
- DE69520376D1 DE69520376D1 DE69520376T DE69520376T DE69520376D1 DE 69520376 D1 DE69520376 D1 DE 69520376D1 DE 69520376 T DE69520376 T DE 69520376T DE 69520376 T DE69520376 T DE 69520376T DE 69520376 D1 DE69520376 D1 DE 69520376D1
- Authority
- DE
- Germany
- Prior art keywords
- vaccine
- sulfolipidic
- adjuvan
- hydrophobic
- polysaccharide containing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
- C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
- C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55583—Polysaccharides
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Materials Engineering (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BE9401174A BE1008978A5 (fr) | 1994-12-27 | 1994-12-27 | Adjuvants pour vaccins. |
PCT/BE1995/000119 WO1996020008A1 (fr) | 1994-12-27 | 1995-12-21 | Adjuvants pour vaccins |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69520376D1 true DE69520376D1 (de) | 2001-04-19 |
DE69520376T2 DE69520376T2 (de) | 2001-08-09 |
Family
ID=3888560
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69520376T Expired - Lifetime DE69520376T2 (de) | 1994-12-27 | 1995-12-21 | Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe |
DE69531699T Expired - Lifetime DE69531699T2 (de) | 1994-12-27 | 1995-12-21 | Cyclodextrinderivate und verfahren zu deren herstellung |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69531699T Expired - Lifetime DE69531699T2 (de) | 1994-12-27 | 1995-12-21 | Cyclodextrinderivate und verfahren zu deren herstellung |
Country Status (17)
Country | Link |
---|---|
US (2) | US6328965B1 (de) |
EP (2) | EP0814836B1 (de) |
JP (2) | JP3927235B2 (de) |
CN (2) | CN1132630C (de) |
AT (2) | ATE199644T1 (de) |
AU (2) | AU713997B2 (de) |
BE (1) | BE1008978A5 (de) |
BR (2) | BR9510223A (de) |
CA (2) | CA2208849C (de) |
DE (2) | DE69520376T2 (de) |
DK (2) | DK0814836T3 (de) |
ES (2) | ES2204969T3 (de) |
GR (1) | GR3035941T3 (de) |
MX (1) | MX9704822A (de) |
PT (2) | PT800539E (de) |
SI (1) | SI0800539T1 (de) |
WO (2) | WO1996020222A1 (de) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE1008978A5 (fr) * | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
US5916883A (en) | 1996-11-01 | 1999-06-29 | Poly-Med, Inc. | Acylated cyclodextrin derivatives |
AU734180B2 (en) * | 1997-08-29 | 2001-06-07 | Antigenics Llc | Compositions comprising the adjuvant qs-21 and polysorbate or cyclodextrin as excipient |
EP1104767A1 (de) | 1999-11-30 | 2001-06-06 | Stichting Dienst Landbouwkundig Onderzoek | Mono- und Disaccharidederivate die sowohl Fettsäureestern als Sulfatestern enthalten |
AT408150B (de) * | 2000-04-14 | 2001-09-25 | Oesterr Forsch Seibersdorf | Verfahren zur immobilisierung eines analyten an einer festen oberfläche |
FR2808691B1 (fr) | 2000-05-12 | 2005-06-24 | Coletica | Cyclodextrines substituees preferentiellement sur leur face primaire par des fonctions acide ou amine |
FR2825714B1 (fr) * | 2001-06-08 | 2005-03-25 | Seppic Sa | Nouvelle utilisation de complexes d'inclusion de cyclodestrine |
MX339524B (es) | 2001-10-11 | 2016-05-30 | Wyeth Corp | Composiciones inmunogenicas novedosas para la prevencion y tratamiento de enfermedad meningococica. |
AU2003220685A1 (en) * | 2002-04-09 | 2003-10-27 | Greenville Hospital System | Metastasis modulating activity of highly sulfated oligosaccharides |
NZ627167A (en) * | 2003-10-16 | 2015-10-30 | Stephen John Ralph | Immunomodulating compositions and uses therefor |
ES2473665T3 (es) | 2005-11-28 | 2014-07-07 | Verrow Pharmaceuticals, Inc. | Composiciones útiles para reducir la nefrotoxicidad y los métodos de uso de las mismas |
US20090017064A1 (en) * | 2007-07-10 | 2009-01-15 | Wyeth | Methods and Compositions for Immunizing Pigs Against Porcine Circovirus |
EP2217271B1 (de) | 2007-11-06 | 2016-05-04 | Zoetis Services LLC | Avirulenter adjuvierter lebendimpfstoff gegen mycoplasma hyopneumoniae |
EP2062594A1 (de) * | 2007-11-21 | 2009-05-27 | Wyeth Farma, S.A. | Impfstoff und immunogene Zusammensetzung gegen den Blauzungenvirus, Verfahren zu deren Verwendung und Verfahren zu deren Herstellung |
US8192721B2 (en) * | 2007-12-13 | 2012-06-05 | Verrow Pharmaceuticals, Inc. | Compositions useful for reducing toxicity associated with gadolinium-based contrast agents |
MY158231A (en) | 2009-06-22 | 2016-09-15 | Wyeth Llc | Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions |
US8568735B2 (en) | 2009-06-22 | 2013-10-29 | Wyeth Llc | Immunogenic compositions of Staphylococcus aureus antigens |
US20110110980A1 (en) * | 2009-09-02 | 2011-05-12 | Wyeth Llc | Heterlogous prime-boost immunization regimen |
EP2397484A1 (de) | 2010-06-11 | 2011-12-21 | Immunovo B.V. | Trisaccharidderivate und ihre Verwendung als Adjuvantien |
EP3831406B1 (de) | 2010-08-23 | 2024-06-05 | Wyeth LLC | Stabile formulierungen von neisseria-meningitidis-rlp2086-antigenen |
AU2011300409B2 (en) | 2010-09-10 | 2015-03-26 | Wyeth Llc | Non-lipidated variants of Neisseria meningitidis ORF2086 antigens |
CN101972477B (zh) * | 2010-10-21 | 2012-09-26 | 中国医学科学院医学生物学研究所 | 磷酸锌疫苗佐剂 |
US20130259896A1 (en) | 2010-12-22 | 2013-10-03 | Lakshmi Khandke | Stable Immunogenic Compositions of Staphylococcus Aureus Antigens |
MX351993B (es) | 2012-03-09 | 2017-11-03 | Pfizer | Composiciones de neisseria meningitidis y metodos de las mismas. |
SA115360586B1 (ar) | 2012-03-09 | 2017-04-12 | فايزر انك | تركيبات لعلاج الالتهاب السحائي البكتيري وطرق لتحضيرها |
UA114504C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs |
US9120859B2 (en) | 2012-04-04 | 2015-09-01 | Zoetis Services Llc | Mycoplasma hyopneumoniae vaccine |
UA114503C2 (uk) | 2012-04-04 | 2017-06-26 | Зоетіс Сервісіз Ллс | Комбінована вакцина pcv та mycoplasma hyopneumoniae |
PT3363806T (pt) | 2012-12-20 | 2022-12-16 | Pfizer | Processo de glicoconjugação |
CA2903716C (en) | 2013-03-08 | 2019-04-09 | Pfizer Inc. | Immunogenic fusion polypeptides |
MX369534B (es) | 2013-09-08 | 2019-11-11 | Pfizer | Composiciones de neisseria meningitidis y sus metodos. |
CA2925281C (en) | 2013-09-25 | 2022-05-03 | Zoetis Services Llc | Pcv2b divergent vaccine composition and methods of use |
CN104013955B (zh) * | 2014-06-18 | 2016-02-24 | 中国科学院过程工程研究所 | 一种不含表面活性剂的水包油乳液及其用途 |
CN104086676B (zh) * | 2014-07-18 | 2017-01-25 | 江苏省农业科学院 | 一种环糊精酯化衍生物、制备方法及其应用 |
BR112017001121B1 (pt) * | 2014-07-24 | 2023-11-07 | Litevax B.V. | Adjuvantes |
RU2723045C2 (ru) | 2015-02-19 | 2020-06-08 | Пфайзер Инк. | Композиции neisseria meningitidis и способы их получения |
IL297740A (en) | 2015-05-04 | 2022-12-01 | Pfizer | Protein-polysaccharide conjugates of group b streptococcus, methods for preparing the conjugates, immunogenic preparations containing conjugates and their uses |
US10751402B2 (en) | 2016-11-09 | 2020-08-25 | Pfizer Inc. | Immunogenic compositions and uses thereof |
JP7010961B2 (ja) | 2017-01-31 | 2022-02-10 | ファイザー・インク | 髄膜炎菌組成物およびその方法 |
CN106928378A (zh) * | 2017-03-29 | 2017-07-07 | 中国药科大学 | 一种十二酰基‑β‑环糊精的制备方法和用于色氨酸手性拆分的聚砜膜的制备方法 |
WO2019178601A1 (en) | 2018-03-16 | 2019-09-19 | Zoetis Services Llc | Peptide vaccines against interleukin-31 |
CA3192786A1 (en) | 2020-08-26 | 2022-03-03 | Pfizer Inc. | Group b streptococcus polysaccharide-protein conjugates, methods for producing conjugates, immunogenic compositions comprising conjugates, and uses thereof |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3565887A (en) * | 1968-05-15 | 1971-02-23 | Corn Products Co | Unsaturated and long chain esters of cyclodextrin |
US4247535A (en) * | 1979-11-05 | 1981-01-27 | American Cyanamid Company | Modified cyclodextrin sulfate salts as complement inhibitors |
US5658894A (en) * | 1989-04-23 | 1997-08-19 | The Trustees Of The University Of Pennsylvania | Compositions for inhibiting restenosis |
US5760015A (en) * | 1988-01-19 | 1998-06-02 | The Trustees Of The University Of Pennsylvania | Cyclodextrin compounds and methods of making and use thereof |
KR0166088B1 (ko) * | 1990-01-23 | 1999-01-15 | . | 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도 |
WO1991013100A1 (en) * | 1990-03-02 | 1991-09-05 | Australian Commercial Research & Development Limited | Cyclodextrin compositions and methods for pharmaceutical and industrial applications |
FR2672496B3 (fr) * | 1990-07-18 | 1993-05-28 | Vacsyn France Sa | Compositions a base de substances hydrophobes, solubilisables dans un solvant aqueux, leur procede d'obtention, et leurs utilisations notamment dans le domaine pharmaceutique. |
US5180716A (en) * | 1990-08-01 | 1993-01-19 | The Regents Of The University Of California | Cyclodextrin complexes for neuraxial administration of drugs |
IT1242214B (it) * | 1990-11-13 | 1994-03-03 | Emo Chiellini | Derivati polifunzionali delle ciclodestrine |
JP2556236B2 (ja) * | 1991-08-29 | 1996-11-20 | 田辺製薬株式会社 | β−シクロデキストリン誘導体のポリ硫酸エステル及びその製法 |
JP3723231B2 (ja) * | 1991-12-23 | 2005-12-07 | ディミナコ アクチェンゲゼルシャフト | アジュバント |
WO1993017711A1 (en) * | 1992-03-11 | 1993-09-16 | Australian Commercial Research & Development Limited | New cyclodextrins and new formulated drugs |
DE4220734A1 (de) * | 1992-06-25 | 1994-01-05 | Puetter Medice Chem Pharm | Lipophile Cyclodextrinpolymere |
US5464827A (en) * | 1994-06-20 | 1995-11-07 | American Home Products Corporation | Esterified polyanionic cyclodextrins as smooth muscle cell proliferation inhibitors |
BE1008978A5 (fr) * | 1994-12-27 | 1996-10-01 | Solvay | Adjuvants pour vaccins. |
-
1994
- 1994-12-27 BE BE9401174A patent/BE1008978A5/fr active
-
1995
- 1995-12-21 SI SI9530679T patent/SI0800539T1/xx unknown
- 1995-12-21 EP EP95942007A patent/EP0814836B1/de not_active Expired - Lifetime
- 1995-12-21 EP EP95942008A patent/EP0800539B1/de not_active Expired - Lifetime
- 1995-12-21 AT AT95942007T patent/ATE199644T1/de active
- 1995-12-21 WO PCT/BE1995/000120 patent/WO1996020222A1/en active IP Right Grant
- 1995-12-21 DE DE69520376T patent/DE69520376T2/de not_active Expired - Lifetime
- 1995-12-21 DK DK95942007T patent/DK0814836T3/da active
- 1995-12-21 ES ES95942008T patent/ES2204969T3/es not_active Expired - Lifetime
- 1995-12-21 AU AU43249/96A patent/AU713997B2/en not_active Ceased
- 1995-12-21 AT AT95942008T patent/ATE248863T1/de active
- 1995-12-21 DE DE69531699T patent/DE69531699T2/de not_active Expired - Lifetime
- 1995-12-21 BR BR9510223A patent/BR9510223A/pt not_active IP Right Cessation
- 1995-12-21 PT PT95942008T patent/PT800539E/pt unknown
- 1995-12-21 CN CN95197099A patent/CN1132630C/zh not_active Expired - Lifetime
- 1995-12-21 DK DK95942008T patent/DK0800539T3/da active
- 1995-12-21 CN CN95197557A patent/CN1109049C/zh not_active Expired - Lifetime
- 1995-12-21 JP JP52008196A patent/JP3927235B2/ja not_active Expired - Lifetime
- 1995-12-21 WO PCT/BE1995/000119 patent/WO1996020008A1/fr active IP Right Grant
- 1995-12-21 MX MX9704822A patent/MX9704822A/es unknown
- 1995-12-21 US US08/860,453 patent/US6328965B1/en not_active Expired - Lifetime
- 1995-12-21 CA CA002208849A patent/CA2208849C/en not_active Expired - Lifetime
- 1995-12-21 US US08/860,454 patent/US6165995A/en not_active Expired - Lifetime
- 1995-12-21 BR BR9510263A patent/BR9510263A/pt not_active IP Right Cessation
- 1995-12-21 ES ES95942007T patent/ES2155540T3/es not_active Expired - Lifetime
- 1995-12-21 AU AU43248/96A patent/AU709104B2/en not_active Ceased
- 1995-12-21 CA CA2208790A patent/CA2208790C/en not_active Expired - Lifetime
- 1995-12-21 JP JP52008296A patent/JP4087900B2/ja not_active Expired - Lifetime
- 1995-12-21 PT PT95942007T patent/PT814836E/pt unknown
-
2001
- 2001-05-28 GR GR20010400796T patent/GR3035941T3/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69520376D1 (de) | Ein hydrophobisches sulfolipidisches polysaccharid enthaltendes adjuvans für impfstoffe | |
ES2109929T3 (es) | Procedimiento para preparar un glucano de levadura | |
PT91856A (pt) | Processo de preparacao de uma matriz com actividade imunomodulante, a base lipido e saponina | |
DE69529684T2 (de) | Adjuvans für impfstoff | |
ES2061055T3 (es) | Vacunas y vectores de principios activos fluidos que contienen un aceite metabolizable. | |
NO308126B1 (no) | Fosfolipidbasert forbindelse, anvendelse derav samt røntgenkontrastmiddel | |
EA200000711A1 (ru) | 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, СПОСОБ ПОЛУЧЕНИЯ ФАРМАЦЕВТИЧЕСКИХ ПРЕПАРАТОВ, СОДЕРЖАЩИХ ЭТИ 11β-ГАЛОГЕН-7α-ЗАМЕЩЕННЫЕ ЭСТРАТРИЕНЫ, И ИХ ПРИМЕНЕНИЕ ДЛЯ ИЗГОТОВЛЕНИЯ ЛЕКАРСТВЕННЫХ СРЕДСТВ | |
PT98156A (pt) | Um processo de preparacao de uma composicao de vacina | |
FI902347A0 (fi) | Menetelmä lasilevyn kiinnittämiseksi metallirakenteeseen ja lasilevyjen ja metallirakenteiden välinen kokoonpano | |
ES2037742T3 (es) | Procedimiento de obtencion de una composicion para administracion intravenosa. | |
DE59006868D1 (de) | 2-Alkyl-4-arylmethylaminochinoline, ihre Verwendung und daraus hergestellte Arzneimittel. | |
ES2062805T3 (es) | Procedimiento para la preparacion de sulfatos ciclicos. | |
ES2119779T3 (es) | Solubilizacion de proteinas en formas activas. | |
EP0527977A4 (en) | Nematode vaccine | |
HUP9801917A2 (hu) | Immunogén készítmény, eljárás annak előállítására és vakcinaként történő alkalmazására | |
ES2146279T3 (es) | 1-ciclopropiltetrazolinonas herbicidas. | |
ES2054281T3 (es) | Disoluciones de pentamidina. | |
ATE164313T1 (de) | Inaktivierte respiratorische synzytial-virus- impfstoffe | |
NZ511118A (en) | Activation of cellular immunity with antigenic proteins and hydrophobized polysaccharides, which have modified alkyl or cholesterol groups | |
Hayashi et al. | A Survey on the Sex Difference for Truck-Driver | |
AR246955A1 (es) | Metodo para la preparacion de clorhidrato del acido ¡ ¡ ¡ ¡ ¡ | |
M Shoukry | Visual damage, clinical course and visual prognosis in capsular glaucoma and simplex glaucoma | |
ES2042198T3 (es) | Un marco. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: PFIZER AG, ZUERICH, CH |